{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:29:50Z","timestamp":1792783790963,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Danish Research Foundation"}],"content-domain":{"domain":["clinicalkey.jp","thebonejournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.bone.2016.07.019","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T08:22:24Z","timestamp":1469521344000},"page":"122-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"special_numbering":"C","title":["A randomized, double-blind, multicenter, placebo-controlled study to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of osteoporosis in postmenopausal women taking calcium and vitamin D"],"prefix":"10.1016","volume":"91","author":[{"given":"Kim","family":"Henriksen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger","family":"Byrjalsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeppe R.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asger R.","family":"Bihlet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis A.","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Alexandersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo","family":"Valter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Qvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bente J.","family":"Riis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten A.","family":"Karsdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.bone.2016.07.019_bb0005","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1056\/NEJMra053077","article-title":"Bone quality\u2013the material and structural basis of bone strength and fragility","volume":"354","author":"Seeman","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2016.07.019_bb0010","first-page":"1","article-title":"The safety and tolerability profile of therapies for the prevention and treatment of osteoporosis in postmenopausal women","author":"Komm","year":"2015","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.bone.2016.07.019_bb0015","first-page":"1","article-title":"Novel targets for the prevention of osteoporosis - lessons learned from studies of metabolic bone disorders","author":"Henriksen","year":"2015","journal-title":"Expert Opin. Ther. Targets"},{"issue":"11","key":"10.1016\/j.bone.2016.07.019_bb0020","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2174\/092986730611220401164504","article-title":"Calcitonin","volume":"6","author":"Sexton","year":"1999","journal-title":"Curr. Med. Chem."},{"issue":"8","key":"10.1016\/j.bone.2016.07.019_bb0025","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1359\/jbmr.080310","article-title":"Calcitonin receptor plays a physiological role to protect against hypercalcemia in mice","volume":"23","author":"Davey","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2016.07.019_bb0030","article-title":"The calcitonin receptor expressed by osteoclasts plays a biological role to protect against induced hypercalcemia in mice. Abstract 1049. 24, suppl 1-abstract","author":"Turner","year":"2009","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.bone.2016.07.019_bb0035","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1056\/NEJM198101293040505","article-title":"Calcitonin: physiology and pathophysiology","volume":"304","author":"Austin","year":"1981","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2016.07.019_bb0040","series-title":"Physiology and Pharmacology","article-title":"The calcitonins","author":"Azria","year":"1989"},{"issue":"4","key":"10.1016\/j.bone.2016.07.019_bb0045","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0002-9343(00)00490-3","article-title":"A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group","volume":"109","author":"Chesnut","year":"2000","journal-title":"Am. J. Med."},{"issue":"3","key":"10.1016\/j.bone.2016.07.019_bb0050","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.bone.2005.04.032","article-title":"Oral salmon calcitonin induced suppression of urinary collagen type II degradation in postmenopausal women: a new potential treatment of osteoarthritis","volume":"37","author":"Bagger","year":"2005","journal-title":"Bone"},{"issue":"9","key":"10.1016\/j.bone.2016.07.019_bb0055","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1359\/JBMR.040715","article-title":"Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women: acute and 3-month effects on biomarkers of bone turnover","volume":"19","author":"Tanko","year":"2004","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.bone.2016.07.019_bb0060","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.joca.2014.12.019","article-title":"Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: results from two phase 3 trials","volume":"23","author":"Karsdal","year":"2015","journal-title":"Osteoarthr. Cartil."},{"issue":"5","key":"10.1016\/j.bone.2016.07.019_bb0065","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1111\/bcp.12557","article-title":"Lessons learned from the clinical development of oral peptides","volume":"79","author":"Karsdal","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.bone.2016.07.019_bb0070","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/0091270008329552","article-title":"A pharmacokinetic and pharmacodynamic comparison of synthetic and recombinant oral salmon calcitonin","volume":"49","author":"Karsdal","year":"2009","journal-title":"J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.bone.2016.07.019_bb0075","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1365-2125.2009.03371.x","article-title":"Influence of food intake on the bioavailability and efficacy of oral calcitonin","volume":"67","author":"Karsdal","year":"2009","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bone.2016.07.019_bb0080","article-title":"The effect of oral salmon calcitonin delivered with 5-CNAC on bone and cartilage degradation in osteoarthritic patients: a 14-day randomized study","author":"Karsdal","year":"2009","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.bone.2016.07.019_bb0085","article-title":"Investigations of inter- and intraindividual relationships between exposure to oral salmon calcitonin and a surrogate marker of pharmacodynamic efficacy","author":"Karsdal","year":"2009","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"9","key":"10.1016\/j.bone.2016.07.019_bb0090","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","article-title":"Vertebral fracture assessment using a semiquantitative technique","volume":"8","author":"Genant","year":"1993","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2016.07.019_bb0095","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1472-6904-8-12","article-title":"Investigation of the diurnal variation in bone resorption for optimal drug delivery and efficacy in osteoporosis with oral calcitonin","volume":"8","author":"Karsdal","year":"2008","journal-title":"BMC Clin. Pharmacol."},{"issue":"8","key":"10.1016\/j.bone.2016.07.019_bb0100","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.bone.2016.07.019_bb0105","doi-asserted-by":"publisher","first-page":"4118","DOI":"10.1210\/jcem.85.11.6953","article-title":"Fracture risk reduction with alendronate in women with osteoporosis: the fracture intervention trial. FIT research group","volume":"85","author":"Black","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"18","key":"10.1016\/j.bone.2016.07.019_bb0110","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1056\/NEJMoa074941","article-title":"Zoledronic acid and clinical fractures and mortality after hip fracture","volume":"357","author":"Lyles","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.bone.2016.07.019_bb0115","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00198-007-0490-1","article-title":"Salmon calcitonin: a review of current and future therapeutic indications","volume":"19","author":"Chesnut","year":"2008","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2016.07.019_bb0120","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1602","article-title":"A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: the ORACAL trial","author":"Binkley","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2016.07.019_bb0125","article-title":"Safety and efficacy of orally administered recombinant salmon calcitonin tablets in the prevention of postmenopausal osteoporosis in women with low bone mass: a phase 2 placebo-controlled trial. Presentation number: 1233","author":"Binkley","year":"2014","journal-title":"J. Bone. Miner. Res."},{"issue":"4","key":"10.1016\/j.bone.2016.07.019_bb0130","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/S0002-9343(00)00539-8","article-title":"What PROOF proves about calcitonin and clinical trials","volume":"109","author":"Cummings","year":"2000","journal-title":"Am. J. Med."},{"issue":"12","key":"10.1016\/j.bone.2016.07.019_bb0135","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1111\/jgs.13167","article-title":"Cancer risk associated with calcitonin use","volume":"62","author":"Lempicki","year":"2014","journal-title":"J. Am. Geriatr. Soc."},{"issue":"11","key":"10.1016\/j.bone.2016.07.019_bb0140","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1210\/jc.2014-2239","article-title":"Calcitonin nasal spray and increased cancer risk: a population-based nested case-control study","volume":"99","author":"Sun","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.bone.2016.07.019_bb0145","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1177\/1060028013509233","article-title":"Salmon calcitonin use and associated cancer risk","volume":"47","author":"Overman","year":"2013","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.bone.2016.07.019_bb0150","article-title":"Does salmon calcitonin cause cancer? A review and meta-analysis","author":"Wells","year":"2015","journal-title":"Osteoporos. Int."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328216302071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328216302071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T16:56:33Z","timestamp":1656867393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328216302071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":30,"alternative-id":["S8756328216302071"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2016.07.019","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A randomized, double-blind, multicenter, placebo-controlled study to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of osteoporosis in postmenopausal women taking calcium and vitamin D","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2016.07.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}